DekaBank Deutsche Girozentrale
PAND

DekaBank Deutsche Girozentrale’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,000
Closed -$539K – 1435
2021
Q1 		$539K Hold
9,000
– – ﹤0.01% 1015
2020
Q4 		$137K Buy
+9,000
New +$125K ﹤0.01% 1236

DekaBank Deutsche Girozentrale's PAND Position: Q2 2021 in Review

DekaBank Deutsche Girozentrale sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 9,000 shares — an estimated $539K sold.

DekaBank Deutsche Girozentrale first reported a position in PAND in Q4 2020 and held it in 2 quarters. The position peaked at $539K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 9,000 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $539K.
  • DekaBank Deutsche Girozentrale first reported a position in Pandion Therapeutics Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Pandion Therapeutics Inc. Common Stock position peaked at $539K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.